SEKISUI MEDICAL aspires to become the most outstanding global medical company in the world in medical fields, such as in vitro diagnostics.

HOME > Topics
To Previous Page

Topics

Important Notification

Apr, 2008
Concerning the Inauguration of SEKISUI MEDICAL CO., LTD.

Other

Dec. 12, 2011
Notification of holiday
May 17, 2011
Launch of “Soluble LR11 measurement reagents”
May 17, 2011
Application for National Health Insurance on “Clinichip®HPV” to Detect Thirteen Genotypes of High-risk Human Papillomavirus
Apr. 15, 2011
Notification of holiday
Apr. 04, 2011
Resumption of the operations of ADME & Tox Research Institute
Mar. 02, 2011
Enhancement of Peptide Medical Business<Sekisui Medical and JITSUBO sign a joint development contract>
Feb. 01, 2011
Establishment of new companies and change in companies' names following the acquisition of U.S.-based Genzyme Corporation's Diagnostics Business【Sekisui Chemical Co., Ltd.】
Dec. 14, 2010
Sanko Junyaku and Sekisui Medical Conclude Exclusive Japan Marketing Agreement for Influenza Test Kit RapidTesta® FLU II
Dec. 13, 2010
Notification of holiday
Nov. 18, 2010
Acquisition of U.S.-based Genzyme Corporation's Diagnostics Business 【Sekisui Chemical Co., Ltd.】
Oct. 6, 2010
Launch of “Clinical Automated Analyzer EV800” under Sekisui Medical brand
Aug. 2, 2010
Contract signed for OEM supply of blood coagulation analyzers and dedicated reagents to the European and South American markets
June. 10, 2010
International recruitment is now open.
Application period:June 10th to July 14th 2010.
Apr. 19, 2010
Notification of holiday
Mar. 2, 2010
Enhancement of Medical Business in China
Dec. 7, 2009
Notification of holiday
July 1, 2009
SEKISUI MEDICAL CO., LTD, announces launching the products of XenoTech, LLC
June 19, 2009
Information and application for international recruitment
Apr. 17, 2009
Notification of holiday
Mar. 19, 2009
Diagnostic Reagents Business Formally Expands Overseas By Acquisition of U.S. Company
Dec. 9, 2008
Notification of holiday
July 9, 2008
Sekisui America Corporation Announces Acquisition of XenoTech, L.L.C. Acquisition expands the pharmacokinetics contract services business of Sekisui Medical in the U.S. markets 【Sekisui Chemical Co., Ltd.】
To Previous Page